寧鳳玲

學(xué)歷：理學(xué)博士

郵箱：[email protected]

通訊地址：云南省昆明市呈貢區(qū)雨花街道春融西路1168號(hào)

郵編：650500

教育與工作經(jīng)歷

2014.09-2018.06,，復(fù)旦大學(xué),，藥學(xué)院,，學(xué)士

2018.09-2024.06，復(fù)旦大學(xué),，藥學(xué)院，博士

2024.09-至今,，昆明醫(yī)科大學(xué),，生物醫(yī)學(xué)工程研究院

研究方向

基于泛素化酶為靶點(diǎn)的小分子化合物抗腫瘤活性篩選，與藥物的新機(jī)制研究,。

研究成果

1. Ning F#, Du L#, Li J, Wu T, Zhou J, Chen Z, Hu X, Zhang Y, Luan X, Xin H*, Yuan C*, Zhang X*. (2024). The deubiquitinase USP5 promotes cholangiocarcinoma progression by stabilizing YBX1. Life Sci. 348:122674.

2. Ning F#, Tao J#, Li D, Tian L, Wang M, Reilly S, Liu C, Cai H, Xin H*, Zhang X*. (2022). Activating BK channels ameliorates vascular smooth muscle calcification through Akt signaling. Acta Pharmacol Sin. 43(3):624-633.  

3. Wang Y, Wang M, Ning F, Ren D, Tao J, Xie W, Douglas C Eaton, Jiang G, Alton B Farris, Xin H, Cai H, Zhang X*. (2022). A novel role of BK potassium channel activity in preventing the development of kidney fibrosis. Kidney Int. 101(5):945-962.

4. Ning F#, Xin H#, Liu J, Lv C, Xu X, Wang M, Wang Y, Zhang W*, Zhang X*. (2020). Structure and function of USP5: Insight into physiological and pathophysiological roles. Pharmacol Res. 157:104557.